A5082660814- Venous Thromboembolism Diagnosis and Management
- COVID-19 Clinical Research Studies
- Atrial Fibrillation Management and Outcomes
- Healthcare Systems and Public Health
- Acute Myocardial Infarction Research
- Acute Ischemic Stroke Management
- Cardiovascular Disease and Adiposity
- Long-Term Effects of COVID-19
- COVID-19 Impact on Reproduction
- Cardiovascular Health and Risk Factors
- COVID-19 and healthcare impacts
- Blood Coagulation and Thrombosis Mechanisms
- Eosinophilic Disorders and Syndromes
- Cardiovascular Issues in Pregnancy
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Systemic Lupus Erythematosus Research
- Blood Pressure and Hypertension Studies
- Artificial Intelligence in Healthcare
- SARS-CoV-2 and COVID-19 Research
- Kawasaki Disease and Coronary Complications
- Aortic Disease and Treatment Approaches
- Blood groups and transfusion
- Cardiac Arrhythmias and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Ultrasound in Clinical Applications
Harvard University
2021-2025
Brigham and Women's Hospital
2021-2025
Rochester General Hospital
2024
Office of Education
2024
Hospital Universitario Ramón y Cajal
2023
University Hospital of Geneva
2023
Abstract Background Contemporary pulmonary embolism (PE) research, in many cases, relies on data from electronic health records (EHRs) and administrative databases that use International Classification of Diseases (ICD) codes. Natural language processing (NLP) tools can be used for automated chart review patient identification. However, there remains uncertainty with the validity ICD-10 codes or NLP algorithms Methods The PE-EHR+ study has been designed to validate as Principal Discharge...
Coronavirus disease 2019 (COVID-19) is associated with excess risk of cardiovascular and thrombotic events in the early post-infection period during convalescence. Despite progress our understanding complications, uncertainty persists respect to more recent event rates, temporal trends, association between vaccination status outcomes, findings within vulnerable subgroups such as older adults (aged 65 years or older), those undergoing hemodialysis. Sex-informed findings, including results...
Essentials•Randomized trials suggest that direct oral anticoagulants (DOACs) may not be as safe or effective for mangement of venous thromboembolism (VTE) in certain situations.•We review scenarios where DOACs are and effective, they have reduced safety efficacy, when their and/or efficacy uncertain.•DOACs advised VTE antiphospholipid syndrome luminal cancers.•The remain uncertain some conditions.AbstractDirect become the preferred option treatment due to favorable profile compared with...
Sex differences exist in risk factors and comorbidities of older adults (aged ⩾ 65 years) with pulmonary embolism (PE). Clinically relevant sex-based treatment disparities for PE have not been adequately addressed. The few existing show conflicting results due to small sample size (type II error) suboptimal methods (overreliance on
Abstract Patients with acute venous thromboembolism (VTE) in the setting of transient provoking factors are typically treated short-term anticoagulation. However, risk recurrence may be increased presence enduring factors. In such patients, optimal duration treatment remains uncertain. HI-PRO is a single-center, double-blind randomized trial. deep vein thrombosis (DVT) or pulmonary embolism (PE) following major factor, including surgery trauma, who completed at least 3 months standard-dose...
ABSTRACT Graduate professional development is a highly dynamic enterprise that prepares graduate students for personal and career success in variety of fields, including the biosciences. National policies, funding awards, institutional programs have generated myriad tools services bioscience students, new learning resources, events, connections to prospective employers, opportunities strengthen academic portfolios. These interventions are welcome done much enhance training, but they may also...
IntroductionPregnancy may contribute to an excess risk of thrombotic or cardiovascular events. COVID-19 increases the these events, although is relatively limited among outpatients. We sought determine whether outpatient pregnant women with are at a high for events.Materials & methodsWe analyzed outpatients from multicenter CORONA-VTE-Network registry. The main study outcomes were composite adjudicated venous arterial and Events assessed 90 days after diagnosis reported non-pregnant ≤45...
Introduction: Patients with COVID-19 are at an increased risk of cardiovascular complications. Studies indicating association between ABO blood groups and outcomes were limited by small sample size or use administrative claims data uncertain validity. Aim: To study the non-O group among patients in a large cohort adjudicated events. Methods: We examined from CORONA-VTE Network registry confirmed data. The main outcome was major events including venous arterial thrombosis, heart failure,...